LEDERMAN SETH Insider Trades

Insider Trading History

Track insider trading activity for LEDERMAN SETH. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $99.6k 9,005 shares
Last Trade
Jun 09, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$59k 5,000 shares
$11.79
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $221k 20,001 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$63.1k 5,000 shares
$12.62
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $166k 15,001 shares
Last Trade
Mar 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$223k 15,000 shares
$14.89
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $1.49M 134,504 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 134,504 shares
$14.29
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $1.49M 134,503 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 134,503 shares
$14.29
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $44.3k 4,005 shares
Last Trade
May 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$86.2k 4,000 shares
$21.55
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $1.37M 123,958 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$998k 123,958 shares
$8.05
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $1.37M 123,958 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$998k 123,958 shares
$8.05
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $11.1 1 shares
Last Trade
Feb 05, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$0 0 shares
$14.98
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $55.3 5 shares
Last Trade
Feb 05, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$74.9 5 shares
$14.98
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Feb 05, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$15 1 shares
$14.98
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $21.1M 1,903,680 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.06B 3,448,911 shares
$1,177.60
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $14.5M 1,309,911 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.54B 1,309,911 shares
$1,177.60
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $7.74M 700,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.2B 700,000 shares
$14,622.02
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $7.74M 700,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.2B 700,000 shares
$14,622.02
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $268k 24,235 shares
Last Trade
Jun 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$664M 20,000 shares
$33,200.00
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $1.24M 112,177 shares
Last Trade
Mar 25, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.7B 100,000 shares
$147,200.00
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $55.3M 5,000,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662B 5,000,000 shares
$132,352.00
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $55.3M 5,000,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662B 5,000,000 shares
$132,352.00
$11.06
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Executive Officer
Holding Value $55.3M 5,000,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662B 5,000,000 shares
$132,352.00
$11.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up